Stock listing

TPEx:6976 Acepodia, Inc. (育世博-KY) 股價

Follow Acepodia, Inc. into a list and get an email when it puts out news.

Share price · TPEX:6976

$9.20 TWD -0.80 (-8.0%)

Close on Nov 20, 2026

Past year -37.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$8.45 – $10.05 TWDNov 20, 2026
Volume
676,075 sharesNov 20, 2026
Market cap
$5.36B TWDAt the close on Nov 20, 2026 · price × 582.9M shares outstanding
52-week range
$8.45 – $17.40 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$6.09M TWDMedian day 399,989 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Acepodia, Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6976 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$9.20-0.80-8.0%$10.00$10.05$8.45676,075
$10.00-0.05-0.5%$9.75$10.40$9.71385,879
$10.05-0.70-6.5%$10.75$10.85$9.85961,525
$10.75-1.20-10.0%$11.95$11.95$10.601,576,179
$11.95+0.05+0.4%$11.90$11.95$11.60141,577
$11.90-0.10-0.8%$12.00$12.00$11.60189,918
$12.00-0.10-0.8%$11.85$12.20$11.85117,235
$12.10-0.25-2.0%$12.35$12.40$11.80210,204
$12.35+0.40+3.3%$12.00$12.45$11.85408,307
$11.95-0.30-2.4%$12.25$12.25$11.40569,245
$12.25-0.50-3.9%$12.35$12.75$12.05512,482
$12.75+0.30+2.4%$12.30$13.00$12.30260,461
$12.45-0.30-2.4%$13.15$13.15$12.20442,375
$12.75-0.05-0.4%$13.15$13.15$12.75182,911
$12.80-0.55-4.1%$13.35$13.35$12.75221,712
$13.35+0.35+2.7%$13.05$13.45$13.00216,762
$13.00-0.05-0.4%$12.80$13.10$12.60301,655
$13.05-0.30-2.2%$13.15$13.35$12.85472,653
$13.350.000.0%$13.35$13.35$13.350
$13.35+0.10+0.8%$13.40$13.45$13.15384,641
$13.25-0.10-0.7%$13.45$13.45$13.20333,421
$13.35+0.35+2.7%$13.25$13.45$13.00651,063
$13.00-0.15-1.1%$13.00$13.35$12.90501,255
$13.15-0.05-0.4%$13.20$13.45$13.15230,807
$13.20-0.10-0.8%$13.35$13.45$13.00693,669
$13.300.000.0%$13.15$13.45$13.15247,504
$13.30+0.05+0.4%$13.45$13.45$13.10463,704
$13.25-0.15-1.1%$13.60$13.60$13.15634,333
$13.40-0.10-0.7%$13.55$13.55$13.20527,630
$13.50+0.35+2.7%$13.50$13.55$13.10892,270
$13.15+0.20+1.5%$13.10$13.55$12.901,294,156
$12.95+0.15+1.2%$12.85$13.05$12.65777,010
$12.80+0.15+1.2%$12.85$12.95$12.65357,200
$12.65-0.20-1.6%$12.95$12.95$12.65242,808
$12.85-0.05-0.4%$13.00$13.00$12.65453,315
$12.90+0.05+0.4%$12.90$13.40$12.80545,903
$12.85-0.15-1.2%$13.10$13.10$12.70329,205
$13.00+0.35+2.8%$12.80$13.15$12.75406,825
$12.65-0.45-3.4%$13.15$13.15$12.501,083,982
$13.100.000.0%$13.30$13.35$12.95393,153
$13.10-0.35-2.6%$13.45$13.45$12.95779,413
$13.45+0.40+3.1%$13.10$13.85$12.95872,323
$13.05+0.50+4.0%$12.70$13.30$12.65686,487
$12.55-0.05-0.4%$12.60$12.75$12.30415,612
$12.60+0.25+2.0%$12.45$12.75$12.45492,248
$12.35-0.30-2.4%$12.75$12.75$12.25239,596
$12.65+0.05+0.4%$12.45$12.80$12.30358,662
$12.60+0.10+0.8%$12.60$12.65$12.35375,533
$12.50-0.65-4.9%$13.35$13.35$12.15556,979
$13.15+1.05+8.7%$11.95$13.90$11.952,317,679
$12.10+0.10+0.8%$12.00$12.15$11.65360,846
$12.00+0.15+1.3%$12.00$12.05$11.65417,466
$11.85-0.10-0.8%$11.95$11.95$11.75435,108
$11.950.000.0%$11.85$11.95$11.80208,204
$11.95-0.10-0.8%$11.85$12.05$11.75367,006
$12.05+0.05+0.4%$11.75$12.20$11.65280,160
$12.00+0.20+1.7%$11.70$12.35$11.70325,157
$11.80-0.25-2.1%$12.05$12.05$11.70188,354
$12.05-0.15-1.2%$12.20$12.20$11.65248,059
$12.20+0.15+1.2%$11.95$12.30$11.65616,464
$12.05+0.05+0.4%$11.80$12.05$11.80204,759
$12.000.000.0%$11.95$12.00$11.75163,459
Ticker
TPEx:6976
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TPEx
Currency
TWD

What changed lately

Latest news

All Acepodia, Inc. news

Acepodia, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 2 in all · newest Sep 4, 2026 · oldest 2026

Valuation

EV/sales 10,415× against a median of 15.5×: the highest of 9 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$1.93B TWD
P/E
Loss
EV/sales
10,415×
EV/EBITDA
Negative EBITDA
Price/book
1.1×
Gross margin
65.4%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Acepodia, Inc. · TPEX:6976US$162.7MUS$58.45Mn/a10,415×n/a1.1×n/a0.0×n/a
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H · HKEX:2591US$170.8MUS$39.93Mn/a2.1×n/a1.2×−259.6%0.2×n/a
Entrada Therapeutics, Inc. · NASDAQ:TRDAUS$170.3MUS$24.60Mn/a6.2×n/a0.9×n/a0.2×1.43
SinoMab Bioscience Ltd. · HKEX:3681US$166.3MUS$172.4Mn/an/an/a3.1×n/a0.7×n/a
Prestige BioPharma Limited · KRX:950210US$164.7MUS$131.9Mn/a6.8×n/a0.5×−350.9%0.1×n/a
TaiGen Biopharmaceuticals Holdings Limited · TPEX:4157US$161.1MUS$133.3M34.2×17.1×46.8×5.2×60.5%0.0×n/a
Baijin Life Science Holdings Limited · HKEX:1466US$160.0MUS$158.1Mn/a13.9×n/a6.8×−42.4%0.1×n/a
ImmuneOncia Therapeutics Inc. · KRX:424870US$159.0MUS$89.79Mn/an/an/a2.1×n/a0.0×n/a
Jiangsu Recbio Technology Co., Ltd. Class H · HKEX:2179US$157.3MUS$230.2Mn/a124×n/a2.1×n/a1.4×n/a
BioVersys AG · SIX:BIOVUS$154.1MUS$97.45Mn/a102×n/a2.9×n/a0.5×n/a
InflaRx N.V. · NASDAQ:IFRXUS$153.3MUS$135.7Mn/a4,215×n/a19.5×n/a0.0×1.61
Median of the othersUS$160.5MUS$132.6M34.2×15.5×46.8×2.5×−151.0%0.2×1.52

Team and board

Officers

OfficerRole
Sonny HsiaoCEO

Board

DirectorRole
Patrick YangChairman of the Board
Carolyn BertozziNominated Board Member
Sonny HsiaoCEO

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue185.0K427.0K16.6M00
Cost of revenue64.0K149.0K0
Gross profit121.0K278.0K16.6M
Research and development806.8M612.7M310.9M341.6M303.5M115.5M
Selling, general and administrative162.6M145.5M141.6M176.0M173.8M34.1M
Operating income-969.2M-757.9M-811.7M-1.41B-477.3M-149.6M
Depreciation and amortization115.2M80.7M47.2M23.0M12.1M4.29M
EBITDA-854.0M-677.2M-764.5M-1.39B-465.2M-145.4M
Interest expense6.01M6.49M4.84M1.51M798.0K60.0K
Income before tax-763.3M-473.0M-816.5M-1.41B-878.5M-455.0M
Income tax776.0K-400.4M-305.3M
Net income-754.4M-496.7M-817.3M-1.41B-878.5M-455.0M
Earnings per share, basic-1.30-0.87-1.44-30.79-77.69-40.23

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents3.80B5.87B6.29B3.73B1.55B225.6M
Short-term investments262.3M2.21B
Receivables0122.0K0
Current assets3.94B6.19B6.34B3.78B3.80B231.4M
Total assets5.83B6.82B6.82B3.87B3.90B253.2M
Current liabilities194.4M206.1M137.6M125.8M95.1M18.6M
Total debt273.8M52.4M53.8M6.95M
Total liabilities415.1M479.2M384.5M6.88B5.36B963.5M
Shareholders' equity5.42B6.34B6.43B-3.01B-1.46B-710.2M
Shares outstanding582.2M573.7M567.0M45.9M11.3M11.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-707.3M-369.0M-282.7M-372.8M-357.9M-103.4M
Capital spending-72.9M-127.8M-179.4M-7.71M-28.7M-3.62M
Free cash flow-780.2M-496.8M-462.1M-380.5M-386.6M-107.0M
Cash from financing3.00B-9.63M3.98B-1.29M
Change in cash-2.07B-425.2M2.57B2.18B1.32B-118.9M

Open Financials

Cap table

Built by 6ix from Acepodia, Inc.’s releases

Common shares
582,867,110
Fully diluted
582,867,110

Fully diluted

LineShares
Common shares582,867,110

Share count over time

CountShares
Nov 22, 2026582,867,110

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
Digital Mobile Venture LTD.209M35.9%Oct 31, 2026
Yungscience Co.,ltd.19.9M3.4%Oct 31, 2026
蔡高忠1.35M0.23%Oct 31, 2026
唐賽文1.14M0.19%Oct 31, 2026
賴彥達1.1M0.19%Oct 31, 2026
魏少筠600K0.10%Oct 31, 2026
Wang Yajun王亞君83,2180.01%Oct 31, 2026
蕭世嘉10,000<0.01%Oct 31, 2026
黃佳凱7,000<0.01%Oct 31, 2026
郭頌鑫00.00%Oct 31, 2026
All 17 holders
HolderSharesOf the companyAs of
Carolyn R. Bertozzi00.00%Oct 31, 2026
周家瑋00.00%Oct 31, 2026
符懋榆00.00%Oct 31, 2026
陳賢哲00.00%Oct 31, 2026
馬海怡00.00%Oct 31, 2026
饒坤銘00.00%Oct 31, 2026
蔡欣能00.00%Oct 31, 2026

Funds

HolderSharesValueAs of
State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF214KUS$89,492Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sonny HsiaoCEO · Since at least Sep 4, 2026

Open People

Log in to ask 6ix AI your own questions about Acepodia, Inc.